Lighthouse Financial’s Relay Therapeutics RLAY Stock Holding History

Lighthouse Financial’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$389K	Buy	+21,543	New	+$413K	0.18%	66

Other funds holding RLAY

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Lighthouse Financial's RLAY Position: Q3 2026 in Review

Lighthouse Financial opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 21,543 shares worth $389K. The stake represents 0.18% of the portfolio and ranks #66 among its holdings.

24 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

Lighthouse Financial held 21,543 shares of Relay Therapeutics worth $389K as of Q3 2026.
Relay Therapeutics was a new Lighthouse Financial position in Q3 2026.
Relay Therapeutics made up 0.18% of Lighthouse Financial's portfolio in Q3 2026, its #66 holding.
24 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Lighthouse Financial's 13F filing for Q3 2026, filed 23 Oct 2026.